2016
DOI: 10.1016/j.archoralbio.2016.08.019
|View full text |Cite
|
Sign up to set email alerts
|

BMP2 and BMP4 variations and risk of non-syndromic cleft lip and palate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(20 citation statements)
references
References 20 publications
0
20
0
Order By: Relevance
“…Thus, a total of 11 eligible publications were finally included in the present meta-analysis. [ 13 15 , 19 – 26 ] The characteristics of the included studies are presented in Table 1 . Of these studies, seven were hospital-based case–control designs, and 4 were population-based case–control designs.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, a total of 11 eligible publications were finally included in the present meta-analysis. [ 13 15 , 19 – 26 ] The characteristics of the included studies are presented in Table 1 . Of these studies, seven were hospital-based case–control designs, and 4 were population-based case–control designs.…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, more relevant human genetic association studies have been published among different populations since then, and the association results are not consistent. [ 12 – 15 ] We, therefore, conducted an updated meta-analysis to assess the association between BMP4 rs17563 polymorphism and NSCL/P risk. The allele frequencies of BMP4 rs17563 among groups were also pooled in the current meta-analysis, which, to our knowledge, have not been investigated before.…”
Section: Introductionmentioning
confidence: 99%
“…Recent other studies of BMP2 gene rs235768 A> T on orofacial cleft has been taken place. A previous study in Tehran, Iran 16 , with a total sample of 107 orofacial cleft and 186 controls showed that BMP2 gene rs235768 A> T genotype was significantly higher (p = 0.009, OR = 3.95%) between both groups. At the same time, the allele distribution was also significantly higher than the control group, which indicated the T allele as a risk factor, with OR = 2.2%.…”
Section: Discussionmentioning
confidence: 86%
“…There is also evidence that PAX1 is upregulated by SHH, and in turn, upregulates SOX5 and BMP4 (41)(42)(43). There is only a limited literature describing PAX1 expression in the developing face (38) and it has not been previously associated with risk to nonsyndromic OFCs, but PAX1 is in a pathway with other genes known to be associated with nonsyndromic OFCs (44)(45)(46)(47)(48)(49). Additionally, recent studies have shown mutations in PAX1 cause otofaciocervical syndrome (OTFCS, MIM#615560) which presents with facial dysmorphisms (50,51), and studies of normal facial variation have found this locus has also been associated with nasal width (the distance between left and right cartilaginous nasal ala) in people of European descent (52) and in people of Latin American descent (53).…”
Section: Discussionmentioning
confidence: 99%